SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-04-000019
Filing Date
2004-01-07
Accepted
2004-01-07 17:21:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AND AMENDMENTS s13d_0106-2004onyx.txt SC 13D/A 19285
  Complete submission text file 0000904454-04-000019.txt   21140
Mailing Address 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45955 | Film No.: 04513801
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE PALMER SQ PRINCETON NJ 08542
Business Address ONE PALMER SQ PRINCETON NJ 08542
DOMAIN PARTNERS IV LP (Filed by) CIK: 0001077714 (see all company filings)